drugset / Trial / NCT00225199

Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

NCT00225199

Phase 3 Completed 198 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to demonstrate safety and efficacy of SH T00660AA compared to placebo in the treatment of endometriosis

Timeline

Start
2004-03
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule Oral

Indications